What is Skriber?
Skriber is at the forefront of revolutionizing healthcare administration through its advanced AI technology. The platform is meticulously designed to automate the generation of accurate, structured SOAP notes, thereby alleviating the administrative burden on healthcare professionals. By offloading the complexities of clinical documentation, Skriber empowers physicians and clinicians to dedicate more time to direct patient care, enhancing both efficiency and the quality of medical services. The company's focus on streamlining the documentation process positions it as a key player in the digital health transformation, addressing a critical pain point in modern healthcare delivery.
How much funding has Skriber raised?
Skriber has raised a total of $1.3M across 1 funding round:
Angel/Pre-Seed
$1.3M
Angel/Pre-Seed (2025): $1.3M with participation from Seeds2B Africa and Morgan Creek Capital Management
Key Investors in Skriber
Seeds2B Africa
Seeds2B Africa is a company based in Kenya focused on agricultural solutions, indicating a potential interest in diverse investment opportunities beyond its primary sector.
Morgan Creek Capital Management
Morgan Creek Capital Management is an asset manager with a thematic investment approach, focusing on innovative technology and secular trends, suggesting a strategic alignment with Skriber's AI-driven health-tech solutions.
What's next for Skriber?
With the recent influx of major strategic capital, Skriber is poised for an accelerated growth trajectory. The company is likely to leverage this investment to expand its technological capabilities, enhance its AI algorithms for even greater accuracy and efficiency, and broaden its market reach. Strategic partnerships and further product development are anticipated as Skriber aims to solidify its position as an indispensable tool for healthcare providers seeking to optimize their workflows and improve patient outcomes. The enterprise-level funding signals strong investor confidence in Skriber's business model and its potential to disrupt the medical scribe market.
See full Skriber company page
